DEBRA LUCAS FRAILING: Open Payments
NPI 1972264703 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 56 payments from 14 companies in 2025. Trend: 2023 $691 · 2024 $700 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $189 |
| ABBVIE INC. | 13 | $151 |
| Alkermes, Inc. | 8 | $148 |
| Neurocrine BioSciences, Inc. | 5 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $86 |
| Lundbeck LLC | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
Products named: REXULTI, VRAYLAR, ARISTADA, INGREZZA, CAPLYTA, INVEGA SUSTENNA, Jornay PM, Auvelity.
Industry payments across CO — which companies pay providers there.
